| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/CLC.4960160508 |
| P698 | PubMed publication ID | 8504575 |
| P2093 | author name string | H Ogawa | |
| K Yamauchi | |||
| H Saito | |||
| H Hayashi | |||
| T Watanabe | |||
| N Mizutani | |||
| T Sone | |||
| H Hirayama | |||
| F Takatsu | |||
| J Osugi | |||
| P2860 | cites work | Acute myocardial infarction: Intracoronary application of nitroglycerin and streptokinase | Q28217998 |
| Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial | Q34258431 | ||
| A randomised dose ranging study of recombinant tissue plasminogen activator in acute myocardial infarction. | Q36896962 | ||
| A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction | Q41783750 | ||
| Tissue plasminogen activator: Toronto (TPAT) placebo-controlled randomized trial in acute myocardial infarction | Q49171664 | ||
| Characteristics and outcome of patients in whom reperfusion with intravenous tissue-type plasminogen activator fails: results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) I trial. | Q64948383 | ||
| Regional wall motion improvement after coronary thrombolysis with recombinant tissue plasminogen activator: importance of coronary angioplasty | Q67299493 | ||
| Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial | Q69367792 | ||
| Measurement of regional wall motion from biplane contrast ventriculograms: a comparison of the 30 degree right anterior oblique and 60 degree left anterior oblique projections in patients with acute myocardial infarction | Q69615493 | ||
| Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty | Q69912387 | ||
| A multicenter, randomized, placebo-controlled trial of a new form of intravenous recombinant tissue-type plasminogen activator (activase) in acute myocardial infarction | Q70030233 | ||
| Improvement in regional wall motion after percutaneous transluminal coronary angioplasty during acute myocardial infarction: utility of two-dimensional echocardiography | Q70055394 | ||
| Immediate vs delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction. TIMI II A results. The TIMI Research Group | Q70063699 | ||
| The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial | Q70331348 | ||
| Community hospital administration of intravenous tissue plasminogen activator in acute myocardial infarction: improved timing, thrombolytic efficacy and ventricular function | Q70367082 | ||
| Limitation of myocardial infarction by early infusion of recombinant tissue-type plasminogen activator | Q70388870 | ||
| P433 | issue | 5 | |
| P921 | main subject | acute myocardial infarction | Q18558122 |
| P304 | page(s) | 409-414 | |
| P577 | publication date | 1993-05-01 | |
| P1433 | published in | Clinical Cardiology | Q4502312 |
| P1476 | title | Effects of intravenous SM-9527 (double-chain tissue plasminogen activator) on left ventricular function in the chronic stage of acute myocardial infarction | |
| P478 | volume | 16 |
Search more.